流行病学,诊断策略和治疗进展在分散的中线质瘤
Gloria Miguel Llordes1,2, Víctor Manuel Medina Pérez1, Beatriz Curto Simón3
1Molecular Oncology Group, Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009 Zaragoza, Spain.
Journal of clinical medicine
|August 26, 2023
概括
扩散性中线结质瘤 (DMG),一个儿科脑瘤,现在被重新分类并扩大其人口统计. 分子洞察力正在指导新的,量身定制的疗法,尽管需要更多的临床试验来确定有效性.
科学领域:
- 神经瘤学神经瘤学
- 儿科瘤学 儿科瘤学
- 遗传学 遗传学 是一个
背景情况:
- 扩散中线质瘤 (DMG) 是一种致命的儿科脑瘤,以前被称为扩散内在质质瘤 (DIPG).
- 最近的世卫组织CNS5重新分类扩大了DMG人口统计.
- 治疗选择有限和预后不佳凸显了对新型治疗方法的需求.
研究的目的:
- 系统地审查扩散中线质瘤 (DMG) 的诊断和治疗.
- 为了汇总从2012年1月到2023年7月的当前信息.
- 根据分子洞察力确定新兴的治疗策略.
主要方法:
- 按照PRISMA指南进行系统的文献审查.
- 在PubMed,Cochrane图书馆和SciELO数据库中进行了搜索.
- 专注于2012年1月至2023年7月期间发表的研究.
主要成果:
- 分子分类对于DMG预后和治疗选择至关重要.
- 新兴疗法包括免疫调节剂,CAR T-细胞/NK疗法,血脑屏障透技术,IDH抑制剂和疫苗.
- 进一步的临床试验对于建立毒性,剂量和疗效指南至关重要.
结论:
- 鉴定H3K27突变导致DMG重新分类和人口扩张.
- 高度具体,量身定制的治疗策略对于DMG治疗成功至关重要.
- 目前正在进行的研究表明,在扩散的中线质瘤中改善结果是有前途的.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...


